July 7, 2021
Sosei Group said on July 6 that it has entered into an R&D collaboration with InveniAI, aiming for a multi-target G protein-coupled receptors (GPCRs)-focused drug discovery with the US upstart’s AI-based platform. Under the partnership, the companies aim to identify...read more